ECONOMYNEXT – Sri Lanka received another four million doses of the Chinese Sinopharm COVID-19 vaccine on Saturday (18), the final batch of an order placed by the State Pharmaceutical Corporation (SPC).
The Chinese embassy in Sri Lanka tweeted that the consignment sees the conclusion of a contract the SPC had entered with the manufacturer.
Sri Lanka has received a total of 26 million doses of Sinopharm to date. It is the most widely used vaccine in the island, with over 10 million people getting the first dose, out of whom over 8 million have been fully vaccinated.
By Friday (17) 13.72 million has received the first dose of one of the five COVID-19 vaccines administered in Sri Lanka, while 10.9 million have received both first and second doses.
State Minister of Production, Supply and Regulation of Pharmaceuticals Channa Jayasumana said by Friday (17) health authorities had vaccinated 50 percent of the total population.
“In the beginning our main aim was to vaccinate everyone above 30 years old. According to the statistics, by mid-2020, there are approximately 11.5 million people in that above 30 category. We have achieved that target to a considerable level now,” Jayasumana said in an interview by the privately owned Derana network on Saturday (18).
“Then our aim was to vaccinate 20-29 years old. In that group we have 3.3 million. Altogether we have 14.8 million people left to vaccinate,” he said, adding that this will be done with 713,000 doses of the Pfizer-BioNTech vaccine that are due in the comings weeks.
“With yesterday’s decision to vaccinate all in the 15-19 age group, and children with congenital disorders and other comorbidities in the 12-14 age group, we now have a total of 16.7 million people.”
Jayasumana said with 13.7 million being vaccinated with the first dose by Friday (17), another three million still remain to be vaccinated. (Colombo/Sep19/2021)